Skip to main content

Table 8 Correlation between the miPSMA expression score and the other obtained metabolic parameters

From: [68Ga]Ga-PSMA-11 PET before and after initial long-term androgen deprivation in patients with newly diagnosed prostate cancer: a retrospective single-center study

T2/T1-quotient (Q) of miPSMA score Q SUVmax Q LN_SUVmax Q SUVmean Q LN_SUVmean Q PSMA-TV Q TL-PSMA Q LN-TL-PSMA Q PSA T2 PSA
All lesions          
Correlation coefficient 0.970 0.969 0.970 0.969 0.828 0.903 0.896 0.185 0.472
p value  < 0.001  < 0.001  < 0.001  < 0.001  < 0.001  < 0.001  < 0.001 0.057  < 0.001
Primary tumor          
Correlation coefficient 0.874 0.893 0.866 0.885 0.505 0.669 0.666 0.257 0.162
p value  < 0.001  < 0.001  < 0.001  < 0.001 0.012  < 0.001  < 0.001 0.226 0.449
Lymph node metastases          
Correlation coefficient 0.968 0.976 0.967 0.975 0.886 0.933 0.931 0.105 0.484
p value  < 0.001  < 0.001  < 0.001  < 0.001  < 0.001  < 0.001  < 0.001 0.442  < 0.001
Bone metastases          
Correlation coefficient 0.945 0.951 0.945 0.951 0.873 0.917 0.917 0.132 0.547
p value  < 0.001  < 0.001  < 0.001  < 0.001  < 0.001  < 0.001  < 0.001 0.510 0.003
  1. Q, quotient of T2/T1; LN, liver normalization [value divided by hepatic SUVmean]. Significant correclation coefficents and their exact p-value are marked bold